A study of plasma potassium and electrocardiographic changes after a single dose of succinylcholine.
D001285:Atropine; D001919:Bradycardia / Q000139:chemically induced; D002318:Cardiovascular Diseases / Q000150:complications; D003646:Debridement; D048909:Diabetes Complications; D004562:Electrocardiography; D005260:Female; D005831:Genital Diseases, Female / Q000601:surgery; D006321:Heart / Q000187:drug effects*; D006329:Heart Conduction System / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006919:Hydroxyzine; D007275:Injections, Intravenous; D008297:Male; D008614:Meperidine; D009765:Obesity / Q000150:complications; D010424:Pentobarbital; D011188:Potassium / Q000097:blood*; D011229:Preanesthetic Medication; D013390:Succinylcholine / Q000008:administration & dosage* / Q000009:adverse effects; D013610:Tachycardia / Q000139:chemically induced
D006919:Hydroxyzine; D001285:Atropine; D008614:Meperidine; D010424:Pentobarbital; D013390:Succinylcholine; D011188:Potassium